Banys-Paluchowski, Malgorzata
Witzel, Isabell
Aktas, Bahriye http://orcid.org/0000-0002-5474-051X
Fasching, Peter A.
Hartkopf, Andreas
Janni, Wolfgang
Kasimir-Bauer, Sabine
Pantel, Klaus
Schön, Gerhard
Rack, Brigitte
Riethdorf, Sabine
Solomayer, Erich-Franz
Fehm, Tanja
Müller, Volkmar
Article History
Received: 6 October 2018
Accepted: 4 December 2018
First Online: 19 February 2019
Competing Interests
: Wolfgang Janni received a research grant from Roche. Bahriye Aktas has served as a consultant/advisor for Roche, Pfizer, Novartis. Klaus Pantel has served as a consultant/advisor for Agena Bioscience. Sabine Kasimir-Bauer has served as a consultant/advisor for Qiagen. Peter A. Fasching has served as a consultant/advisor for Amgen, Novartis, Roche, Pfizer, Teva, Puma Celgene and received a research grant from Novartis. Brigitte Rack has received honoraria or research grants from Novartis, Roche, Pfizer, Janssen Diagnostics, Astra Zeneca, Novartis, Lilly, Chugai and Sanofi. Malgorzata Banys-Paluchowski has received lecture honoraria from Roche, Novartis and Pfizer. Isabell Witzel, Sabine Riethdorf, Andreas Hartkopf, Gerhard Schön, Erich-Franz Solomayer, Tanja Fehm and Volkmar Müller declare that they have no conflicts of interest. No other conflicts of interest were reported.